A Critical Review of Icosapent Ethyl in Cardiovascular Risk Reduction.
Huston J, Schaffner H, Cox A, Sperry A, Mcgee S, Lor P, Langley L, Skrable B, Ashchi M, Bisharat M, Gore A, Jones T, Sutton D, Sheikh-Ali M, Berner J, Goldfaden R.
Huston J, et al. Among authors: langley l.
Am J Cardiovasc Drugs. 2023 Jul;23(4):393-406. doi: 10.1007/s40256-023-00583-8. Epub 2023 May 15.
Am J Cardiovasc Drugs. 2023.
PMID: 37188993
Free PMC article.
Review.